Medicare Enrolled
Dr. Saima Khurram, MD
Neurology · Canton, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khurram from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khurram?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khurram
Dr. Saima Khurram is a neurology specialist in Canton, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Khurram performed 8,335 Medicare services across 1,106 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khurram received a total of $25,424 from 82 pharmaceutical and/or device companies across 1145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khurram is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 13% volume in GA
$25,424 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,335
Medicare services
Top 13% in GA for neurology
1,106
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~463 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
6,890 | $5 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
431 | $95 | $388 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
278 | $65 | $274 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
116 | $136 | $530 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
102 | $124 | $504 |
| New patient office visit, complex (60-74 min) | 86 | $172 | $664 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
65 | $48 | $187 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
63 | $138 | $541 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
54 | $0 | $4 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
38 | $47 | $184 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
34 | $77 | $287 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
29 | $94 | $344 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
25 | $88 | $322 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
22 | $11 | $55 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
21 | $132 | $508 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
20 | $100 | $385 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
19 | $0 | $4 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
18 | $44 | $167 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $41 | $171 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
11 | $196 | $672 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,424
Total received (2018-2024)
Avg $3,632/year across 7 years
Top 14% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
1,145
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,867 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,557 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,653
2023
$4,100
2022
$3,379
2021
$5,537
2020
$2,757
2019
$2,658
2018
$2,340
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$645
UCB, Inc.
$503
Neurelis, Inc.
$345
Novartis Pharmaceuticals Corporation
$319
MDD US Operations, LLC
$288
Biogen, Inc.
$226
Supernus Pharmaceuticals, Inc.
$211
Neurocrine Biosciences, Inc.
$205
Teva Pharmaceuticals USA, Inc.
$173
Amneal Pharmaceuticals LLC
$142
Lilly USA, LLC
$133
JAZZ PHARMACEUTICALS INC.
$129
Eisai Inc.
$122
ARGENX US, INC.
$122
PFIZER INC.
$121
EMD Serono, Inc.
$112
ANI Pharmaceuticals, Inc.
$107
Lundbeck LLC
$100
Alexion Pharmaceuticals, Inc.
$97
Otsuka America Pharmaceutical, Inc.
$90
Sumitomo Pharma America, Inc.
$89
Octapharma USA, Inc.
$70
Celgene Corporation
$53
AstraZeneca Pharmaceuticals LP
$49
Acorda Therapeutics, Inc
$47
ACADIA Pharmaceuticals Inc
$31
SK Life Science, Inc.
$29
Medtronic, Inc.
$27
Kyowa Kirin, Inc.
$25
CATALYST PHARMACEUTICALS, INC.
$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Top 3 companies account for 32.1% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,876
ABBVIE INC.
$1,696
CATALYST PHARMACEUTICALS, INC.
$1,539
Teva Pharmaceuticals USA, Inc.
$1,364
Novartis Pharmaceuticals Corporation
$1,052
Biogen, Inc.
$975
Neurocrine Biosciences, Inc.
$943
Amneal Pharmaceuticals LLC
$931
EMD Serono, Inc.
$883
Alexion Pharmaceuticals, Inc.
$771
Sunovion Pharmaceuticals Inc.
$765
Neurelis, Inc.
$751
AbbVie Inc.
$650
Lilly USA, LLC
$497
Lundbeck LLC
$474
MDD US Operations, LLC
$468
Allergan, Inc.
$462
Supernus Pharmaceuticals, Inc.
$432
ACADIA Pharmaceuticals Inc
$422
Adamas Pharmaceuticals, Inc.
$400
Greenwich Biosciences, Inc.
$368
SK Life Science, Inc.
$334
Allergan Inc.
$320
PFIZER INC.
$319
Acorda Therapeutics, Inc
$270
US WorldMeds, LLC
$263
ARGENX US, INC.
$263
Amgen Inc.
$262
Avanir Pharmaceuticals, Inc.
$261
Grifols USA, LLC
$259
JAZZ PHARMACEUTICALS INC.
$251
Sumitomo Pharma America, Inc.
$248
GENZYME CORPORATION
$228
HARMONY BIOSCIENCES LLC
$219
Bausch Health US, LLC
$215
Takeda Pharmaceuticals U.S.A., Inc.
$211
Biohaven Pharmaceuticals, Inc.
$208
AbbVie, Inc.
$196
BANNER LIFE SCIENCES, LLC
$186
Kyowa Kirin, Inc.
$174
CSL Behring
$170
Janssen Pharmaceuticals, Inc
$170
UPSHER-SMITH LABORATORIES LLC
$165
Eisai Inc.
$163
Harmony Biosciences LLC
$160
Celgene Corporation
$148
Avion Pharmaceuticals
$148
Otsuka America Pharmaceutical, Inc.
$147
Upsher-Smith Laboratories LLC
$136
IMPEL PHARMACEUTICALS INC.
$126
Octapharma USA, Inc.
$112
Medtronic, Inc.
$110
ANI Pharmaceuticals, Inc.
$107
AstraZeneca Pharmaceuticals LP
$104
Promius Pharma LLC
$81
Biohaven Pharmaceutical Holding Company Ltd.
$80
Catalyst Pharmaceuticals, Inc.
$77
Jazz Pharmaceuticals Inc.
$61
Aprecia Pharmaceuticals, LLC
$58
Banner Life Sciences, LLC
$56
Vanda Pharmaceuticals Inc.
$51
Genentech USA, Inc.
$49
GE Healthcare
$48
EISAI INC.
$45
Azurity Pharmaceuticals, Inc.
$44
Impax Laboratories, Inc.
$44
SANOFI-AVENTIS U.S. LLC
$39
Boston Scientific Corporation
$34
Mallinckrodt LLC
$31
Cala Health, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$25
Abbott Laboratories
$24
ITI, Inc.
$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Arbor Pharmaceuticals, Inc.
$20
ASSERTIO THERAPEUTICS, Inc.
$19
Assertio Therapeutics, Inc.
$19
Mallinckrodt Enterprises LLC
$17
Collegium Pharmaceutical, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$16
Mylan Pharmaceuticals Inc.
$16
Vertical Pharmaceuticals, LLC
$11
Top 3 companies account for 20.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CALA TRIO · CAMBIA · CAPLYTA · COLOGUARD DNA CAPTURE REAGENTS · COPAXONE · CREXONT · DUOPA · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Edarbi · Epidiolex · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GENERAL - DBS · GENERAL - THERAPIES · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HETLIOZ · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS ADAPTIVESTIM · INVEGA SUSTENNA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LINZESS · Leqembi · MAVENCLAD · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Privigen · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · Qelbree · RELEXXII · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPRAVATO · SUNOSI · Soliris · Spritam · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · Wakix · Xadago · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
53
Per 100K population
19.3
County median income
$105,442
Nearest hospital
NORTHSIDE HOSPITAL CHEROKEE
7.9 mi
7.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khurram is a mixed practice specialist, with above-average Medicare volume (top 13% in GA), with low-engagement industry engagement in the top 14% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khurram experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Khurram performed 6,890 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khurram receive payments from pharmaceutical companies?
Yes. Dr. Khurram received a total of $25,424 from 82 companies across 1,145 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khurram's costs compare to other neurologists in Canton?
Dr. Khurram's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khurram) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Canton
Browse neurologists in Canton ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
CATALYST PHARMACEUTICALS, INC. Payments to Doctors
See all physicians who received payments from CATALYST PHARMACEUTICALS, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology